Charlotta Grånäs

656 total citations
14 papers, 539 citations indexed

About

Charlotta Grånäs is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Charlotta Grånäs has authored 14 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Organic Chemistry. Recurrent topics in Charlotta Grånäs's work include Receptor Mechanisms and Signaling (6 papers), Neuroscience and Neuropharmacology Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Charlotta Grånäs is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Neuroscience and Neuropharmacology Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Charlotta Grånäs collaborates with scholars based in Sweden, Denmark and United Kingdom. Charlotta Grånäs's co-authors include Claus J. Løland, Ulrik Gether, Jonathan A. Javitch, Jasmine V. Ferrer, Dan Larhammar, Christian Krog-Jensen, Jakob Felding, Christian Montalbetti, Steven P. Butcher and Gunnar Nordvall and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Neuroscience.

In The Last Decade

Charlotta Grånäs

14 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charlotta Grånäs Sweden 11 359 248 104 42 41 14 539
Fanjie Zhang United States 7 471 1.3× 127 0.5× 80 0.8× 51 1.2× 30 0.7× 8 657
Antonio C.M. Paiva Brazil 16 399 1.1× 178 0.7× 58 0.6× 61 1.5× 25 0.6× 41 869
Stephen W. Young United States 11 297 0.8× 107 0.4× 40 0.4× 60 1.4× 33 0.8× 27 486
Michael A. Kjelsberg United States 10 688 1.9× 464 1.9× 103 1.0× 41 1.0× 37 0.9× 13 967
Gregor Reither Germany 12 501 1.4× 97 0.4× 40 0.4× 26 0.6× 87 2.1× 14 650
Randal M. Bugianesi United States 15 621 1.7× 201 0.8× 69 0.7× 18 0.4× 15 0.4× 16 773
Pranab Maiti United States 8 377 1.1× 70 0.3× 41 0.4× 77 1.8× 60 1.5× 11 516
Kwei‐Lan Tsao United States 14 368 1.0× 120 0.5× 220 2.1× 35 0.8× 79 1.9× 22 644
Marijke Somers Belgium 11 349 1.0× 184 0.7× 90 0.9× 45 1.1× 32 0.8× 16 494
Thomas R. Whisenhunt United States 7 455 1.3× 77 0.3× 191 1.8× 44 1.0× 63 1.5× 9 587

Countries citing papers authored by Charlotta Grånäs

Since Specialization
Citations

This map shows the geographic impact of Charlotta Grånäs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotta Grånäs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotta Grånäs more than expected).

Fields of papers citing papers by Charlotta Grånäs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotta Grånäs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotta Grånäs. The network helps show where Charlotta Grånäs may publish in the future.

Co-authorship network of co-authors of Charlotta Grånäs

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotta Grånäs. A scholar is included among the top collaborators of Charlotta Grånäs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotta Grånäs. Charlotta Grånäs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Petersen, L., Allan Beck Christensen, Jacob Andersen, et al.. (2021). Screening of DNA-Encoded Small Molecule Libraries inside a Living Cell. Journal of the American Chemical Society. 143(7). 2751–2756. 46 indexed citations
2.
Behrens, Carsten, Jens Buchardt, Johannes Josef Fels, et al.. (2018). Long-Acting Human Growth Hormone Analogue by Noncovalent Albumin Binding. Bioconjugate Chemistry. 29(9). 3129–3143. 22 indexed citations
3.
Galsgaard, Elisabeth D., Birgitte Rasmussen, Charlotta Grånäs, et al.. (2009). Re-evaluation of the prolactin receptor expression in human breast cancer. Journal of Endocrinology. 201(1). 115–128. 54 indexed citations
4.
Montalbetti, Christian, et al.. (2007). Syntheses and antiproliferative evaluation of oxyphenisatin derivatives. Bioorganic & Medicinal Chemistry Letters. 17(10). 2854–2857. 82 indexed citations
5.
Grånäs, Charlotta, Betina Kerstin Lundholt, Frosty Loechel, et al.. (2006). Identification of RAS-Mitogen-Activated Protein Kinase Signaling Pathway Modulators in an ERF1 Redistribution® Screen. SLAS DISCOVERY. 11(4). 423–434. 14 indexed citations
6.
Montalbetti, Christian, et al.. (2006). Synthetic strategies to prepare 2-alkyl, 2-aryl and 2-acetylenyl substituted 4,6-diamino-1,3,5-triazines. Tetrahedron Letters. 47(33). 5973–5975. 10 indexed citations
7.
Grånäs, Charlotta, Betina Kerstin Lundholt, Arne Heydorn, et al.. (2005). High Content Screening for G Protein-Coupled Receptors Using Cell-Based Protein Translocation Assays. Combinatorial Chemistry & High Throughput Screening. 8(4). 301–309. 26 indexed citations
8.
Løland, Claus J., Charlotta Grånäs, Jonathan A. Javitch, & Ulrik Gether. (2004). Identification of Intracellular Residues in the Dopamine Transporter Critical for Regulation of Transporter Conformation and Cocaine Binding. Journal of Biological Chemistry. 279(5). 3228–3238. 79 indexed citations
9.
Grånäs, Charlotta, Jasmine V. Ferrer, Claus J. Løland, Jonathan A. Javitch, & Ulrik Gether. (2003). N-terminal Truncation of the Dopamine Transporter Abolishes Phorbol Ester- and Substance P Receptor-stimulated Phosphorylation without Impairing Transporter Internalization. Journal of Biological Chemistry. 278(7). 4990–5000. 141 indexed citations
10.
Grånäs, Charlotta, et al.. (2001). Site-directed mutagenesis of the 5-HT1B receptor increases the affinity of 5-HT for the agonist low-affinity conformation and reduces the intrinsic activity of 5-HT. European Journal of Pharmacology. 421(2). 69–76. 8 indexed citations
11.
Grånäs, Charlotta & Dan Larhammar. (1999). Identification of an amino acid residue important for binding of methiothepin and sumatriptan to the human 5-HT1B receptor. European Journal of Pharmacology. 380(2-3). 171–181. 16 indexed citations
12.
Grånäs, Charlotta, Gunnar Nordvall, & Dan Larhammar. (1998). Mutagenesis of the Human 5-HT1BReceptor: Differences from the Closely Related 5-HT1AReceptor and the Role of Residue F331 in Signal Transduction. Journal of Receptors and Signal Transduction. 18(4-6). 225–241. 16 indexed citations
13.
Grånäs, Charlotta, Gunnar Nordvall, & Dan Larhammar. (1998). Site-directed mutagenesis of the human 5-HT1B receptor. European Journal of Pharmacology. 349(2-3). 367–375. 15 indexed citations
14.
Grånäs, Charlotta, Jingquan Yu, Kim L. Huhman, et al.. (1997). Differential distribution of glutamate decarboxylase-65 and glutamate decarboxylase-67 messenger RNAs in the entopeduncular nucleus of the rat. Neuroscience. 78(1). 87–97. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026